Literature DB >> 32321165

Long-term outcomes for patients with limited-stage follicular lymphoma: update of a population-based study.

Andrea C Lo1,2, Belinda A Campbell3, Tom Pickles1,2, Christina Aquino-Parsons1,2, Laurie H Sehn4,5,6, Joseph M Connors4,5,6, Kerry J Savage4,5,6.   

Abstract

Entities:  

Year:  2020        PMID： 32321165     DOI： 10.1182/blood.2019004588

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Stage-specific trends in primary therapy and survival in follicular lymphoma: a nationwide population-based analysis in the Netherlands, 1989-2016.

Authors:  Manette A W Dinnessen; Marjolein W M van der Poel; Sanne H Tonino; Otto Visser; Nicole M A Blijlevens; Daphne de Jong; King H Lam; Marie José Kersten; Pieternella J Lugtenburg; Avinash G Dinmohamed
Journal:  Leukemia       Date:  2020-10-12       Impact factor: 11.528

Review 2.  How we treat mature B-cell neoplasms (indolent B-cell lymphomas).

Authors:  Melissa Lumish; Lorenzo Falchi; Brandon S Imber; Michael Scordo; Gottfried von Keudell; Erel Joffe
Journal:  J Hematol Oncol       Date:  2021-01-06       Impact factor: 17.388

3.  PET-Based Staging Is Cost-Effective in Early-Stage Follicular Lymphoma.

Authors:  Andrea C Lo; Lyndon P James; Anca Prica; Adam Raymakers; Stuart Peacock; Melody Qu; Alex V Louie; Kerry J Savage; Laurie H Sehn; David Hodgson; Joanna C Yang; Hans T T Eich; Andrew Wirth; M G Myriam Hunink
Journal:  J Nucl Med       Date:  2021-08-19       Impact factor: 10.057
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.